Simcere Pharmaceutical Group. (SCR) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts SCR Hot Sheet
Join SI Premium – FREE
Simcere Pharmaceutical Group. (NYSE: SCR) reported Q1 EPS of $0.08, $0.03 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $73.6 million versus the consensus estimate of $79.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
